COYA · Coya Therapeutics, Inc.

$4.76 +0.21 (+4.62%) At close · Sep 4

Market Cap

$111.66M

23.46M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Arun Swaminathan	Chief Executive Officer, Director	$546,000	$395,850	—	$1,149,157	—	—	$2,091,007
Howard Berman	Former Chief Executive Officer, Former Executive Chairman of the Board	$436,800	$316,680	—	$718,221	—	—	$1,471,701
Fred Grossman	President, Chief Medical Officer	$498,160	$288,933	—	$670,340	—	—	$1,457,433
David Snyder	Chief Financial Officer and Chief Operating Officer	$442,000	$256,360	—	$670,340	—	—	$1,368,700

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Howard Berman	Former Chief Executive Officer, Current Executive Chairman of the Board	$553,333	$276,667	—	$1,850,268	—	—	$2,680,268
Fred Grossman	President, Chief Medical Officer	$479,000	$191,600	—	$1,221,838	—	—	$1,892,438
Arun Swaminathan	Chief Executive Officer, Director	$441,667	$185,417	—	$870,084	—	—	$1,497,168
David Snyder	Chief Financial Officer and Chief Operating Officer	$425,000	$170,000	—	$870,084	—	—	$1,465,084

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Howard Berman	Former Chief Executive Officer, Current Executive Chairman of the Board	$580,000	$253,750	—	$483,450	—	—	$1,317,200
David Snyder	Chief Financial Officer and Chief Operating Officer	$425,000	$185,938	—	$336,950	—	—	$947,888
Adrian Hepner	Former President, Chief Medical Officer	$285,208	—	—	$336,950	—	—	$622,158
Fred Grossman	President, Chief Medical Officer	$227,000	$113,500	—	$251,982	—	—	$592,482
Arun Swaminathan	Chief Executive Officer, Director	—	—	—	—	—	—	—

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Adrian Hepner	Former President, Chief Medical Officer	$424,999	$194,792	—	$106,662	—	—	$726,453
David Snyder	Chief Financial Officer and Chief Operating Officer	$279,775	$111,910	—	$216,836	—	—	$608,521
Howard Berman	Chief Executive Officer	$412,500	$185,625	—	—	—	—	$598,125
Fred Grossman	President, Chief Medical Officer	—	—	—	—	—	—	—

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Howard Berman	Chief Executive Officer	$300,000	$90,000	—	—	—	—	$390,000
Adrian Hepner	President, Chief Medical Officer	$70,833	—	—	$56,018	—	—	$126,851
David Snyder	Chief Financial Officer and Chief Operating Officer	—	—	—	—	—	—	—

Executive changes

Person	Role	Change	Effective	Filed
Mark H. Pavao	independent director	Appointed	2026-04-01	2026-04-02
Howard Berman	board of directors	Resigned	2026-04-01	2026-04-02
Howard Berman	Executive Chairman	Resigned	2026-04-01	2026-04-02

Key facts CIK 1835022 CUSIP 22407B108 13F (30d) 40 filings 40 filers Visit website Investor relations